Drug Detail:Solriamfetol (Solriamfetol [ sol-ri-am-fe-tol ])
Drug Class: Miscellaneous central nervous system agents
Solriamfetol Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the use of solriamfetol during breastfeeding. If solriamfetol is required by the mother, it is not a reason to discontinue breastfeeding. Monitor the breastfed infant for adverse reactions, such as agitation, insomnia, poor feeding, and reduced weight gain.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
(Narcolepsy) Amphetamine, Armodafinil, Dextroamphetamine, Lisdexamfetamine, Methylphenidate, Modafinil, Oxybate Salts, Pitolisant
Substance Identification
Substance Name
Solriamfetol
CAS Registry Number
178429-62-4
Drug Class
Breastfeeding
Lactation
Milk, Human
Adrenergic Agents
Carbamates
Central Nervous System Stimulants
Dopamine Agents
Wakefulness-Promoting Agents
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification